Ken Anhalt
In addition to MMS, Ken serves on the board of directors of Doppler Veterinary Network. Prior to joining Lindsay Goldberg, Ken worked as an investor at Blackstone in New York and at Bain Capital in Boston.
Ken earned his MBA from Harvard Business School, where he was a George F. Baker Scholar and the recipient of the John L. Loeb finance award, and his A.B. in Economics from Princeton University.
Suggested For You
news
September 29th, 2026
MMS Shortlisted for Best CRO - Specialist Provider by the 2026 Scrip Awards
perspectives
September 29th, 2026
Getting to First-in-Human Faster: What FDA’s New IND Pilot and NAMs Shift Mean for Sponsors
case study
September 25th, 2026
Driving Decision Making With an Adaptive Clinical Trial Design
news
September 22nd, 2026
MMS Holdings Recognized as one of the UK’s Best Workplaces in BioPharma™
perspectives
September 21st, 2026
From Data to Decisions: Evaluating Bayesian Dynamic Borrowing Before Your Trial Begins
case study
September 18th, 2026
Creating Go/No Go Decision-Making Criteria for Early Stage Studies
webinar
October 29th, 2026
Modernizing SRC and DMC Workflows with Interactive Safety Visualizations
case study
September 15th, 2026
Effective Precision Medicine Strategies With KerusCloud®
case study
September 11th, 2026
How Trial Design Simulation Supports Successful Funding Rounds
perspectives
September 11th, 2026
Navigating the Future of Clinical Trial Transparency: Balancing AI-Driven Anonymization with Human Oversight
case study
September 10th, 2026
Modernizing SRC Workflows Through Integrated Safety Visualizations
case study
September 7th, 2026
Improving Oncology Decision-Making Through Advanced Survival Data Analytics